Obesity-associated activation of angiotensin and endothelin in the cardiovascular system

The renin–angiotensin system (RAS) and the endothelin system have been implicated in the pathogenesis of human cardiovascular and renal diseases, and inhibition of the RAS markedly improves morbidity and survival. Obesity in humans is associated with an increased risk for the development of hyperten...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of biochemistry & cell biology Vol. 35; no. 6; pp. 826 - 837
Main Authors Barton, Matthias, Carmona, Renata, Ortmann, Jana, Krieger, José E., Traupe, Tobias
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.06.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The renin–angiotensin system (RAS) and the endothelin system have been implicated in the pathogenesis of human cardiovascular and renal diseases, and inhibition of the RAS markedly improves morbidity and survival. Obesity in humans is associated with an increased risk for the development of hypertension, atherosclerosis and focal-segmental glomerulosclerosis, however the exact mechanisms underlying these pathologies in obese individuals are not known. This article discusses the clinical importance of obesity and the current evidence for local activation of the renin–angiotensin system and its interactions with the endothelin system in obesity and the cardiovascular pathologies associated with it.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1357-2725
1878-5875
DOI:10.1016/S1357-2725(02)00307-2